Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment

MLA

Xu Sun, et al. “Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment.” Pharmaceuticals, vol. 17, no. 7, July 2024, p. 919. EBSCOhost, https://doi.org/10.3390/ph17070919.

APA

Xu Sun, Xushuang Jia, Zhaolin Tan, Dongmei Fan, Meiqi Chen, Ning Cui, Aidong Liu, & Da Liu. (2024). Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment. Pharmaceuticals, 17(7), 919. https://doi.org/10.3390/ph17070919

Chicago

Xu Sun, Xushuang Jia, Zhaolin Tan, Dongmei Fan, Meiqi Chen, Ning Cui, Aidong Liu, and Da Liu. 2024. “Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment.” Pharmaceuticals 17 (7): 919. doi:10.3390/ph17070919.